Compare PGEN & OOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | OOMA |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 565.7M |
| IPO Year | 2013 | 2015 |
| Metric | PGEN | OOMA |
|---|---|---|
| Price | $8.25 | $20.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $13.65 | ★ $26.60 |
| AVG Volume (30 Days) | ★ 3.6M | 391.3K |
| Earning Date | 11-12-2026 | 08-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 188.46 |
| EPS | 0.03 | ★ 0.20 |
| Revenue | ★ $230,981,000.00 | $114,490,000.00 |
| Revenue This Year | $2,365.68 | $21.68 |
| Revenue Next Year | $85.75 | $4.82 |
| P/E Ratio | $271.00 | ★ $106.70 |
| Revenue Growth | N/A | ★ 9.53 |
| 52 Week Low | $2.99 | $9.79 |
| 52 Week High | $8.27 | $26.19 |
| Indicator | PGEN | OOMA |
|---|---|---|
| Relative Strength Index (RSI) | 72.48 | 35.47 |
| Support Level | $6.41 | $19.66 |
| Resistance Level | N/A | $21.57 |
| Average True Range (ATR) | 0.45 | 0.80 |
| MACD | 0.09 | -0.31 |
| Stochastic Oscillator | 84.01 | 0.65 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that delivers voice and collaboration features, including messaging, intelligent virtual attendants, and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.